Journal profile · Pediatrics
Pediatric Hematology and Oncology
ISSN 0888-0018 · eISSN 1521-0669 · Informa Healthcare · UNITED STATES · Bimonthly · Founded 1986
Pediatric Hematology and Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.26; subscription journal; median 133 days to acceptance (71 articles, last 24 months); community-reported acceptance: easy; 32 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pediatric Hematology and Oncology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life and Hemoglobinopathies and Related Disorders, together about 29.8% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
Source: LetPub
Research area (LetPub): Pediatrics
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Lymphoblastic Leukemia researchMedicine11.9%
- Childhood Cancer Survivors' Quality of LifeMedicine11.1%
- Hemoglobinopathies and Related DisordersMedicine6.8%
- Acute Myeloid Leukemia ResearchMedicine6.5%
- Neuroblastoma Research and TreatmentsMedicine6.1%
- Neutropenia and Cancer InfectionsMedicine4.4%
- Hematopoietic Stem Cell TransplantationMedicine4.4%
- Sarcoma Diagnosis and TreatmentMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.26LetPub ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.39LetPub ·
- SNIP 2026-06
- 0.52LetPub ·
- h-index
- 38LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 1,427OpenAlex ·
- 2-year mean citedness
- 1.14OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 3.48%LetPub ·
Volume
- Articles per year
- 35LetPub ·
Articles by year OpenAlex count · 3,282 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 6 | 4 |
| 2025 | 32 | 8 | 41 |
| 2024 | 42 | 14 | 78 |
| 2023 | 53 | 11 | 189 |
| 2022 | 75 | 17 | 401 |
| 2021 | 93 | 7 | 550 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
133 daysMedian, submission to acceptance · P25–P75 85 days – 163 days
- Acceptance to online
- median 17 days (70 articles)
- Submission to online
- median 151 days
- Sample
- 71 articles with submission and acceptance dates (80 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1986
- ISSN
- 0888-0018
- Electronic ISSN
- 1521-0669
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Pediatric Hematology and Oncology
What CAS zone is Pediatric Hematology and Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pediatric Hematology and Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Oncology / Pediatrics. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pediatric Hematology and Oncology?
The latest impact factor listed by LetPub is 1.26; CiteScore 2.3, h-index 62.
How long does peer review take at Pediatric Hematology and Oncology?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 133 days (interquartile range 85–163 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pediatric Hematology and Oncology?
According to LetPub and DOAJ records, Pediatric Hematology and Oncology is indexed in SCIE and Scopus.
Is Pediatric Hematology and Oncology open access, and what is the APC?
Pediatric Hematology and Oncology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .